Adam Groothuis

Mitralign, Inc. operates as a valve repair company that engages in transcatheter annuloplasty system designed to treat both functional tricuspid regurgitation and mitral regurgitation. The Mitralign Percutaneous Annuloplasty System, MPAS, is intended for the treatment of symptomatic functional mitral regurgitation for annular reduction through tissue plication. The company was founded by Paul A. Spence and Richard P. Geoffrion in 2003 and is headquartered in Tewksbury, MA.

The Brigham & Women's Hospital, Inc. provides health care services. The firm offers treatment for cancer, cardio vascular, neurosciences, orthopedic, arthritis, women's health and clinical services. The company was founded in 1980 and is headquartered in Boston, MA.

CBSET, Inc. is a not-for-profit biomedical research institute located in Lexington, MA. The non-profit company's mission is to advance biomedical research through innovative, high-quality preclinical services to achieve the scientific, regulatory, and commercial goals of its sponsors. CBSET combines top-tier research with operational expertise by providing in vivo studies, in vitro studies, computational and 3D modeling, and complex histopathology services. The company's 40,000-foot, GLP-compliant, OLAW-assured, AAALAC-accredited facility includes vivaria, procedure rooms, catheterization/imaging labs, surgical and necropsy suites, histopathology, SEM, and a range of other technologies.